Biotech

All Articles

Wave surfs DMD effectiveness to regulatory authorities' doors, sending out stock up

.Wave Life Sciences has met its own goal in a Duchenne muscle dystrophy (DMD) research study, positi...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer,...

Achilles splashes cell treatment plan, supports for unemployments after missing 'commercial feasibility' targets

.Achilles Therapeutics has wrecked its own technique. The British biotech is stopping work on its cl...

Aligos advertises phase 2 MASH gain, slashing liver fat approximately 46%

.Aligos Rehabs is trumpeting a midstage win in metabolic-dysfunction associated steatohepatitis (MAS...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work establishing brand new antifungals has gotten a significant increase f...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Having actually scooped up the USA civil rights to Capricor Therapeutics' late-stage Duchenne muscl...

FDA scraps adcomm for Applied's unusual disease medicine

.After pushing back the choice meeting for Applied Therapeutics' metabolic ailment medicine govorest...

Novo inks $600M NanoVation deal to analyze genetic medicines ex-liver

.Novo Nordisk is continuing its push right into hereditary medicines, accepting to compensate NanoVa...

Innovent web links cytokine to colorectal cancer cells responses

.Innovent Biologics has helped make the instance that its checkpoint inhibitor-cytokine fusion prote...

Merck, Daiichi ADC reaches goal in phase 3 lung cancer research study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...